This study evaluates the safety and short- and mid-term outcomes of performing second aortic cross-clamping (2nd XCL) in patients undergoing minimally invasive mitral valve repair (MI-MVr) when the initial repair does not achieve an acceptable result.
This study analyzes the 10-year clinical and echocardiographic outcomes of the randomized PARTNER 2A trial, which compared transcatheter aortic valve implantation using transfemoral or transthoracic transapical or transaortic access with the SAPIEN XT prosthesis versus surgery in patients with severe symptomatic aortic stenosis and intermediate surgical risk.
A critical appraisal of a Spanish first-in-human experience of TAVI valve-in-valve implantation within a previous mechanical prosthesis.
This article reviews the systematic review and meta-analysis by Trevis et al. comparing long-term outcomes after aortic valve replacement (AVR) with mechanical versus bioprosthetic valves in patients aged 50 to 70 years.
The expansion of transcatheter aortic valve implantation avoids open surgery, but also prevents concomitant repair of associated tricuspid regurgitation. This study assesses the consequences of leaving this second valve untreated and seeks to identify which patient profiles might benefit most from conventional combined surgery.
Single-centre retrospective observational study comparing two cardioplegic strategies in patients undergoing minimally invasive mitral valve repair between 2014 and 2025.
Single-centre retrospective propensity score–matched study from Columbia University Irving Medical Center, New York, comparing double valve surgery (DVS) with isolated transcatheter aortic valve replacement (I-TAVR) in patients with severe aortic stenosis and concomitant moderate-to-severe mitral stenosis, with particular focus on heart failure readmissions during follow-up.
Translational study assessing the feasibility of percutaneous implantation of an aortic bioprosthesis within a dysfunctional mechanical valve (ViMech-TAVI), from an animal model to the first-in-human cases.
This article, published in February 2026, provides a concise update on the evaluation and management of tricuspid regurgitation (TR), in light of the major advances in both the diagnostic assessment of tricuspid valve disease and the emergence of new evidence on surgical and transcatheter treatment.
Case series study with 1-year follow-up on tricuspid valve replacement using the patient’s native right atrial appendage instead of an artificial prosthesis.
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.